−0.0465 USD
−3.71 M USD
410.17 K USD
30.10 M
About CNBX Pharmaceuticals Inc.
Sector
Industry
CEO
Eyal Barad
Website
Headquarters
Bethesda
Founded
2004
FIGI
BBG000Q3RYB8
CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CNBX is 0.0102 USD — it has increased by 11.48% in the past 24 hours. Watch CNBX Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CNBX Pharmaceuticals Inc. stocks are traded under the ticker CNBX.
CNBX stock has risen by 25.93% compared to the previous week, the month change is a 0.99% rise, over the last year CNBX Pharmaceuticals Inc. has showed a −22.73% decrease.
CNBX reached its all-time high on Feb 22, 2017 with the price of 109,440.0000 USD, and its all-time low was 0.0050 USD and was reached on Jun 25, 2024. View more price dynamics on CNBX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CNBX stock is 14.75% volatile and has beta coefficient of 2.37. Track CNBX Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is CNBX Pharmaceuticals Inc. there?
Today CNBX Pharmaceuticals Inc. has the market capitalization of 284.67 K, it has increased by 12.96% over the last week.
Yes, you can track CNBX Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
CNBX net income for the last quarter is −130.63 K USD, while the quarter before that showed −325.46 K USD of net income which accounts for 59.86% change. Track more CNBX Pharmaceuticals Inc. financial stats to get the full picture.
No, CNBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 2.00 employees. See our rating of the largest employees — is CNBX Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CNBX Pharmaceuticals Inc. EBITDA is −581.30 K USD, and current EBITDA margin is −187.56%. See more stats in CNBX Pharmaceuticals Inc. financial statements.
Like other stocks, CNBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CNBX Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CNBX Pharmaceuticals Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CNBX Pharmaceuticals Inc. stock shows the sell signal. See more of CNBX Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.